Target intelligence / Profile preview

D-alanyl-D-alanine motif (D-Ala-D-Ala)

Target
D-Ala-D-Ala
Molecular classification
Bacterial cell wall component, Peptidoglycan precursor, Dipeptide motif
01

Overview

The D-alanyl-D-alanine (D-Ala-D-Ala) motif is a critical dipeptide sequence found at the C-terminus of the pentapeptide chain in bacterial peptidoglycan precursors, such as Lipid II (PMID: 11084357). It serves as the essential substrate for transpeptidase enzymes, also known as penicillin-binding proteins, which cross-link the peptidoglycan layers to provide structural integrity and rigidity to the bacterial cell wall (StatPearls, NBK459263). This motif is the primary molecular target for glycopeptide antibiotics, including vancomycin and teicoplanin, which are vital for treating Gram-positive infections (PMID: 15173827). By binding specifically to the D-Ala-D-Ala terminus through five hydrogen bonds, these drugs sterically hinder the transglycosylation and transpeptidation steps of cell wall assembly, ultimately leading to bacterial cell death (PubMed, PMID: 24295361). Clinical resistance often arises through the metabolic substitution of the terminal D-alanine with D-lactate or D-serine, which significantly reduces the binding affinity of the antibiotics (Nature Reviews Microbiology, PMID: 15173827).

Other names
D-Ala-D-Ala terminusD-alanyl-D-alanine dipeptidePeptidoglycan pentapeptide terminusD-alanyl-D-alanine residue
02

Mechanism of action

Glycopeptide antibiotics bind to the D-alanyl-D-alanine terminus of the peptidoglycan precursor Lipid II via a network of hydrogen bonds. This binding sterically inhibits the transglycosylation and transpeptidation reactions catalyzed by penicillin-binding proteins (PBPs), thereby preventing the cross-linking of the bacterial cell wall and leading to osmotic lysis (PMID: 11084357; StatPearls, NBK459263).

03

Biological functions

Bacterial cell wall biosynthesisPeptidoglycan cross-linkingSubstrate for transpeptidation
04

Disease associations

Bacterial infection
05

Safety considerations

NephrotoxicityOtotoxicityRed man syndrome (infusion-related reaction)Development of glycopeptide resistance (e.g., VRE, VRSA)
06

Interacting drugs

Vancomycin

4 more in the full profile.

07

Biomarkers

vanA gene clustervanB gene clusterMinimum Inhibitory Concentration (MIC)D-alanyl-D-lactate (resistance marker)

Beyond the preview

Go deeper on D-alanyl-D-alanine motif (D-Ala-D-Ala).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-alanyl-D-alanine motif (D-Ala-D-Ala).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call